Legal News

Marketing authorisation following Accord v Astellas

Published on: 12 January 2016
Published by: LexisPSL
  • Marketing authorisation following Accord v Astellas
  • Original news
  • What is the background to this case and what declarations did the parties ask for?
  • What was the outcome?
  • Was it right to have Chancery proceedings here, as well as the judicial review proceedings?
  • A reference to the Court of Justice was found premature, but is one needed at some stage on the issues raised here?
  • Does this decision have any broader effect on the industry or the lawyers working within it?

Article summary

IP & IT analysis: What requirements must be met to obtain marketing authorisation (MA) for a medicinal product? Jim Kinnier Wilson, head of life sciences, and Katie Gordon, knowledge lawyer for the IP, IT and commercial team at Penningtons Manches LLP, consider the impact of the judgment in Accord Healthcare v Astellas. or take a trial to read the full analysis.

Popular documents